BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago Gimv Acquires 5% Stake in Azelis, Strengthening Its Investment Portfolio Growth Strategy Gimv Investment Specialty Chemicals Azelis
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago Gimv Anchor acquiert 5% d'Azelis Croissance Investissement Gimv Azelis Chimie Spécialisée
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago Gold by Gold annonce ses résultats annuels 2025 Croissance Chiffre D'affaires Négoce D'or Nouvelle Division Dividende 2025 Résultats Financiers 2025
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago Gold by Gold announces its 2025 annual results Revenue Growth Gold Trading New Division 2025 Financial Results 2025 Dividend
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago OSE Immunotherapeutics Reveals 2025 Financial Results and 2026 Cash Position Financial Results Cash Position Strategic Roadmap Operating Loss OSE Immunotherapeutics
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago OSE Immunotherapeutics dévoile ses résultats financiers pour 2025 et sa trésorerie pour 2026. Résultats Financiers Perte D'exploitation Feuille De Route Stratégique Position De Trésorerie Immunothérapies OSE
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago OSE Immunotherapeutics : Bilan financier de 2025 et perspectives 2026 Partenariats Stratégiques OSE Immunotherapeutics Résultats Financiers 2025 Tedopi® Trésorerie 2026
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago OSE Immunotherapeutics: 2025 Financial Review and 2026 Outlook Strategic Partnerships OSE Immunotherapeutics 2025 Financial Results Tedopi® Cash Flow 2026
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago 74Software Reports 10% Organic Growth in Q1 2026 Organic Growth Recurring Revenue Debt Refinancing Subscription Expansion Q1 2026 Results
BRIEF published on 04/30/2026 at 07:35, 4 months 12 days ago 74Software annonce une croissance organique de 10 % au premier trimestre 2026 Croissance Organique Revenus Récurrents Refinancement De La Dette Résultats Du T1 2026 Extension D'abonnement
Published on 09/12/2026 at 02:35, 9 hours 32 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 13 hours 7 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 14 hours 2 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 14 hours 42 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 19 hours 7 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 4 hours 37 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 13 hours 52 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 13 hours 57 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 16 hours 22 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 17 hours 52 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 5 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 5 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 16 hours ago Availability of the 2026 Interim Financial Report
